|The Commonwealth Medical College|
|City: Scranton||State: PA|
The Commonwealth Medical College is a new school in Scranton, PA. With its first class starting in the 2009-2010 academic year, this is the first year that they are being graded by the AMSA PharmFree Scorecard. The school submitted an extremely strong policies with model policy domains of gifts and meals, consulting relationships, disclosure, samples, sales reps, on and off-site medical education, industry support of trainees and curriculum. The policy could be further strengthened if it included a better pruchasing and formulary committee policy that asked that those who sit on this committee do not have COIs or must recuse themselves to relevant discussions and decisions. Oversight and sanctions are clearly referenced. Overall, this is a very strong policy.
Updates: This is the first submission from this institution to the AMSA Scorecard. As it significantly improved across almost all domains, their grade improved from In Process to an An.
This institution has not granted permission for the posting of their policies on this website for illustrative purposes.
This institution was last evaluated on 4/9/2013.
|Gifts & Meals||Gifts and meals are prohibited regardless of nature or value.|
|Consulting relationships||All consulting arrangements must be reviewed and approved prior to initiation in accordance with appropriate policies by the faculty member's dean, department chair or administrator. The contract must include specific tasks and deliverables, with payment commensurate with the tasks assigned.|
|Industry-funded speaking relationships||All content must be determined by the speaker and should reflect balanced assessment of the current science and treatment options, and the speaker makes clear that the views expressed are the views of the speaker and not that of the company that hired them.|
|Disclosure||Faculty and staff must disclose all ties to industry on an annual basis and/or disclose such relationships to patients when the relationship may represent an apparent conflict of interest. This information will be included on the faculty information pages on a public website.|
|Pharmaceutical samples||Use of drug or device samples at or any affiliated clinics, hospitals or other healthcare facilities will be "judicious and cost-effective". This will be at the the discretion of the appropriate medical care and where there is a specific program in place, the policy must prevent samples from being given directly to physicians by pharmaceutical sales representative. A central distribution and documentation site for drug samples should be established in each healthcare facility that maintains storage of such samples.|
|Purchasing & Formularies||No policy submitted.|
|Industry Sales Representatives||Sales representatives are not allowed to meet with faculty regardless of location, or are not permitted to market their products anywhere inside the medical center and associated clinics and offices except for non-marketing purposes, such as training on devices or equipment.|
|On-campus Education||Industry may contribute unrestricted educational funds to a central fund or oversight body at which, in turn, would disburse funds for programs that are independent of any industry input or control.|
|Attendance at Industry-Sponsored Lectures & Meetings Off-Campus||Faculty and staff may not accept gifts or financial support from industry to attend lectures and meetings.|
|Industry Support for Scholarships & Funds for Trainees||Trainees may accept industry support with the following criteria: Industry support for scholarships and fellowships must comply with all requirements for such funds, including a written pledge agreement through the Development Office. It will be maintained in an appropriate restricted account, managed at the school as determined by the Dean. The School of Medicine department, program or division will select the recipients of such funds, with no involvement by the sponsor.|
|Medical school curriculum||Students are trained to understand institutional COI policies and recognize how industry promotion can influence clinical judgment during orientation and throughout their four years in both preclinical and clinical settings.|
|Do the policies specify an oversight mechanism?||Any violations of this policy should be reported to the Department for Faculty Affairs and Faculty Development or for students to the Regional Associate Deans or the Associate Dean for Admissions and Student Affairs where it will be directed to appropriate supervisory personnel and department deans.|
|Are there explicit sanctions for noncompliance?||Possible consequences of policy violation include but are not limited to: counseling, training, privilege reduction or revocation, requiring repayment of monies acquired in violation of policies, fines or termination.|
|Good progress toward model policy|
|No policy, or policy unlikely to have a substantial effect on behavior|
|Did not report|
|Policy not relevant to this institution (e.g., does not make purchasing decisions)|